| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |